Filter by: patients
What is MS HOPE Study Apoaequorin?

MS HOPE Trial is a randomized, double-blind, placebo controlled quality of life study of the effect of apoaequorin dietary supplement, on quality of life measures and expectations with regard to aging in participants with multiple sclerosis. It is conducted by Quincy Bioscience.

0 patients have reported taking MS HOPE Study Apoaequorin .

Report created on May 26, 2012.